Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-10 4:19 pm Purchase | 2025-04-03 | 13G | Merus N.V. MRUS | Paradigm BioCapital Advisors LP | 3,554,059 5.100% | 3,554,059 (New Position) | Filing History |
| 2025-03-27 4:21 pm Purchase | 2025-03-20 | 13G | LENZ Therapeutics, Inc. LENZ | Paradigm BioCapital Advisors LP | 1,419,832 5.200% | 1,419,832 (New Position) | Filing History |
| 2025-02-14 4:45 pm Purchase | 2024-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Paradigm BioCapital Advisors LP | 7,429,355 9.990% | 1,925,755 (+34.99%) | Filing History |
| 2025-02-14 4:42 pm Sale | 2024-12-31 | 13G | Kura Oncology, Inc. KURA | Paradigm BioCapital Advisors LP | 0 0.000% | -4,331,321 (Position Closed) | Filing History |
| 2025-02-14 4:41 pm Purchase | 2024-12-31 | 13G | Janux Therapeutics, Inc. JANX | Paradigm BioCapital Advisors LP | 3,515,986 6.000% | 907,412 (+34.79%) | Filing History |
| 2025-02-12 4:35 pm Purchase | 2025-02-05 | 13G | Cogent Biosciences, Inc. COGT | Paradigm BioCapital Advisors LP | 5,559,924 5.000% | 5,559,924 (New Position) | Filing History |
| 2025-02-03 4:36 pm Purchase | 2025-01-27 | 13G | Edgewise Therapeutics, Inc. EWTX | Paradigm BioCapital Advisors LP | 4,738,929 5.000% | 4,738,929 (New Position) | Filing History |
| 2024-11-14 4:35 pm Purchase | 2024-09-30 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Paradigm BioCapital Advisors LP | 2,440,445 6.400% | 512,939 (+26.61%) | Filing History |
| 2024-11-14 4:35 pm Purchase | 2024-09-30 | 13G | Arcellx, Inc. ACLX | Paradigm BioCapital Advisors LP | 4,800,000 8.900% | 1,141,376 (+31.20%) | Filing History |
| 2024-11-14 4:35 pm Sale | 2024-09-30 | 13G | COMPASS Pathways plc CMPS | Paradigm BioCapital Advisors LP | 2,320,000 3.300% | -1,105,988 (-32.28%) | Filing History |
| 2024-11-14 4:34 pm Sale | 2024-09-30 | 13G | Olema Pharmaceuticals, Inc. OLMA | Paradigm BioCapital Advisors LP | 5,503,600 9.600% | -2,400,000 (-30.37%) | Filing History |
| 2024-11-14 4:34 pm Purchase | 2024-09-30 | 13G | Nuvalent, Inc. NUVL | Paradigm BioCapital Advisors LP | 5,000,000 7.800% | 1,141,992 (+29.60%) | Filing History |
| 2024-11-14 4:33 pm Sale | 2024-09-30 | 13G | Vor Biopharma Inc. VOR | Paradigm BioCapital Advisors LP | 0 0.000% | -6,457,293 (Position Closed) | Filing History |
| 2024-11-14 4:33 pm Sale | 2024-09-30 | 13G | Viridian Therapeutics, Inc. VRDN | Paradigm BioCapital Advisors LP | 3,509,253 4.600% | -1,795,060 (-33.84%) | Filing History |
| 2024-11-14 4:33 pm Sale | 2024-09-30 | 13G | Disc Medicine, Inc. IRON | Paradigm BioCapital Advisors LP | 1,497,720 5.040% | -888,137 (-37.23%) | Filing History |
| 2024-11-14 4:32 pm Sale | 2024-09-30 | 13G | Bicycle Therapeutics plc BCYC | Paradigm BioCapital Advisors LP | 0 0.000% | -3,707,001 (Position Closed) | Filing History |
| 2024-11-14 4:32 pm Sale | 2024-09-30 | 13G | Autolus Therapeutics plc AUTL | Paradigm BioCapital Advisors LP | 0 0.000% | -12,611,335 (Position Closed) | Filing History |
| 2024-11-14 4:32 pm Purchase | 2024-09-30 | 13G | Y-mAbs Therapeutics, Inc. YMAB | Paradigm BioCapital Advisors LP | 4,086,346 9.200% | 1,888,034 (+85.89%) | Filing History |
| 2024-11-14 4:31 pm Purchase | 2024-09-30 | 13G | Kura Oncology, Inc. KURA | Paradigm BioCapital Advisors LP | 4,331,321 5.700% | 470,003 (+12.17%) | Filing History |
| 2024-10-23 5:39 pm Purchase | 2024-10-16 | 13G | Janux Therapeutics, Inc. JANX | Paradigm BioCapital Advisors LP | 2,608,574 5.000% | 2,608,574 (New Position) | Filing History |